Investors Asset Management of Georgia’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,300	Closed	-$79K	–	617
2022 Q2	$79K	Buy	+1,300	New	+$79K	0.04%	221